drugset / Trial / NCT05468957

Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure

NCT05468957 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transfemoral procedures with 6 French Access. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transfemoral procedures. It is believed that the use of both devices in combination compared to the Perclose alone will shorten the time that it takes to 'seal' the artery, resulting in a shorter period of time that patients would need to lay flat.

Timeline

Start
2022-08-01
Primary completion
2025-07-31
Completion
2025-07-31

Outcome

Outcome not reported

Stopped: “Initiating PI left our institution.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Statseal Unknown — Topical